These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23712107)

  • 1. Systemic iron chelation results in limited functional and histological recovery after traumatic spinal cord injury in rats.
    Sauerbeck A; Schonberg DL; Laws JL; McTigue DM
    Exp Neurol; 2013 Oct; 248():53-61. PubMed ID: 23712107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model.
    Pinzon A; Marcillo A; Quintana A; Stamler S; Bunge MB; Bramlett HM; Dietrich WD
    Brain Res; 2008 Dec; 1243():146-51. PubMed ID: 18838063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exjade (ICL 670): A new oral iron chelator.
    Agarwal MB
    J Assoc Physicians India; 2006 Mar; 54():214-7. PubMed ID: 16800349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deferasirox : a review of its use in the management of transfusional chronic iron overload.
    Yang LP; Keam SJ; Keating GM
    Drugs; 2007; 67(15):2211-30. PubMed ID: 17927285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury.
    Pannu R; Christie DK; Barbosa E; Singh I; Singh AK
    J Neurochem; 2007 Apr; 101(1):182-200. PubMed ID: 17217414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deferasirox (Exjade) for the treatment of iron overload.
    Cappellini MD; Taher A
    Acta Haematol; 2009; 122(2-3):165-73. PubMed ID: 19907154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minocycline treatment inhibits lipid peroxidation, preserves spinal cord ultrastructure, and improves functional outcome after traumatic spinal cord injury in the rat.
    Sonmez E; Kabatas S; Ozen O; Karabay G; Turkoglu S; Ogus E; Yilmaz C; Caner H; Altinors N
    Spine (Phila Pa 1976); 2013 Jul; 38(15):1253-9. PubMed ID: 23370685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium channel blockade with phenytoin protects spinal cord axons, enhances axonal conduction, and improves functional motor recovery after contusion SCI.
    Hains BC; Saab CY; Lo AC; Waxman SG
    Exp Neurol; 2004 Aug; 188(2):365-77. PubMed ID: 15246836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine attenuates morphological deficits in a contusion model of spinal cord injury.
    Ravikumar R; Fugaccia I; Scheff SW; Geddes JW; Srinivasan C; Toborek M
    J Neurotrauma; 2005 Feb; 22(2):240-51. PubMed ID: 15716630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine amide preserves mitochondrial bioenergetics and improves functional recovery following spinal trauma.
    Patel SP; Sullivan PG; Pandya JD; Goldstein GA; VanRooyen JL; Yonutas HM; Eldahan KC; Morehouse J; Magnuson DS; Rabchevsky AG
    Exp Neurol; 2014 Jul; 257():95-105. PubMed ID: 24805071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deferasirox: the new oral iron chelator.
    Dubey AP; Sudha S; Parakh A
    Indian Pediatr; 2007 Aug; 44(8):603-7. PubMed ID: 17827637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of early surgical decompression on functional and histological outcomes after severe experimental thoracic spinal cord injury.
    Jalan D; Saini N; Zaidi M; Pallottie A; Elkabes S; Heary RF
    J Neurosurg Spine; 2017 Jan; 26(1):62-75. PubMed ID: 27636866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and histological characterization of unilateral cervical spinal cord contusion injury in rats.
    Gensel JC; Tovar CA; Hamers FP; Deibert RJ; Beattie MS; Bresnahan JC
    J Neurotrauma; 2006 Jan; 23(1):36-54. PubMed ID: 16430371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The functional and neuroprotective actions of Neu2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury.
    Springer JE; Rao RR; Lim HR; Cho SI; Moon GJ; Lee HY; Park EJ; Noh JS; Gwag BJ
    J Neurotrauma; 2010 Jan; 27(1):139-49. PubMed ID: 19772458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of deferasirox at low and high iron burdens: results from the EPIC magnetic resonance imaging substudy.
    Porter JB; Elalfy MS; Taher AT; Aydinok Y; Chan LL; Lee SH; Sutcharitchan P; Habr D; Martin N; El-Beshlawy A
    Ann Hematol; 2013 Jan; 92(2):211-9. PubMed ID: 23086508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of iron overload and chelation with deferasirox.
    Choudhry VP; Naithani R
    Indian J Pediatr; 2007 Aug; 74(8):759-64. PubMed ID: 17785900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron chelation in the treatment of cancer: a new role for deferasirox?
    Bedford MR; Ford SJ; Horniblow RD; Iqbal TH; Tselepis C
    J Clin Pharmacol; 2013 Sep; 53(9):885-91. PubMed ID: 23740857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Recovery of Carbon Nanotube/Nafion Nanocomposite in Rat Model of Spinal Cord Injury.
    Imani S; Zagari Z; Rezaei Zarchi S; Jorjani M; Nasri S
    Artif Cells Nanomed Biotechnol; 2016; 44(1):144-9. PubMed ID: 25861814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deferasirox.
    Stumpf JL
    Am J Health Syst Pharm; 2007 Mar; 64(6):606-16. PubMed ID: 17353569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnesium in a polyethylene glycol formulation provides neuroprotection after unilateral cervical spinal cord injury.
    Lee JH; Roy J; Sohn HM; Cheong M; Liu J; Stammers AT; Tetzlaff W; Kwon BK
    Spine (Phila Pa 1976); 2010 Nov; 35(23):2041-8. PubMed ID: 20938394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.